Neurol. pro Praxi, 2003; 6: 324-328

Etiopatogenéza zajakavosti vo svetle nových poznatkov

prof. PhDr. Viktor Lechta PhD
Katedra logopédie PdF UK, Centrum pre dysfluencie SZU, Bratislava

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lechta V. Etiopatogenéza zajakavosti vo svetle nových poznatkov. Neurol. praxi. 2003;4(6):324-328.

Zajakavosťou sa dnes zaoberá toľko odborov, že sa dokonca začína používať termín balbutológia ako spoločný termín, vyjadrujúci vzájomný prienik poznatkov z disciplín zacielených na tento problém. Pokiaľ ide o etiológiu vzhľadom na jej možné orgánové pozadie, najnovšie poznatky prinášajú viacero informácií, potvrdzujúcich pravdepodobnú dyskoordináciu mozgových hemisfér. Patogenéza zajakavosti prebieha pravdepodobne v troch fázach (incipientná, fixovaná chronická zajakavosť), pričom v každej z nich má prienik nadmernej námahy, psychickej tenzie a dysfluencie svoje výrazné špecifiká. Ak má byť terapia úspešná, musí tieto špecifiká zohľadniť.

Kľúčové slová

zajakavosť, príčiny zajakavosti, patogenéza zajakavosti.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Böhme G. Sprach-, Sprech-, Stimm- un Schluckstörungen. Stuttgart: G.Fischer 1997.
    2. Cooper EB, Cooper CS. Assessment for Stuttering Syndromes for Children, San Antonio: Harcourt Brace 1995.
    3. Conture G. a kol. Stottern in Theorie und Forschung: Träume der Theorienbildung treffen auf die empirische Wirklichkeit des Forschungsalltagen. SpracheStimme- Gehör, 2001; 25, 1: 1-9. Go to original source...
    4. De Nil LF. Stuttering. A Neurophysiological Perspective. In: Bernstein R.E.Healey, E. CH. a kol.: Stuttering Research and Practice: Bridging the Gap. London: Mahwah 1999: 85-102.
    5. Drayna D. Genetic research on Stuttering. SFA Newsletter, 2000: 7.
    6. Guitar B. Stuttering: an integrated approach to its nature and treatment. Baltimore: Williams&Wilkins 1998.
    7. Gillam RB. Fluency Disorders. In: Gillam RB, a kol. Communication Sciences and Disorders. Delmar: Singular Publishing 2000: 313-340.
    8. Ingham RJ. PET Functional-Lesion Investigation of Stuttering. J. of Speech Hearing Res., 1996; 39: 1208-1215. Go to original source... Go to PubMed...
    9. Johansen HS. Der Einfluß von Alter, Geschlecht, Symptomatologie, Heredität und Händigkeit auf dem Verlauf des Stotterns im Kindesalter. Sprache - StimmeGehör, 2001; 25, 1: 14-19. Go to original source...
    10. Kehoe T D. Stuttering: Science, Therapy & Practice. http://casafuturatech.com.
    11. Kroll RM, De Nil LF. Neural Bases of Stuttering and its Treament. SFA Newsletter, 2000: 2-3.
    12. Kuwata H, Hiroshima SM. Kuwara K. Funktional Mri Study of Developmental Stuttering. J.Fluency Disord. 2000; 25: 256. Go to original source...
    13. Lechta V, a kol. Diagnostika narušenej komunikačnej schopnosti. Martin: Osveta 1995.
    14. Lechta V, a kol. Terapia narušenej komunikačnej schopnosti. Martin: Osveta 2002.
    15. Logan R. The Three Dimensions of Stuttering: Neurology, Behaviour and Emotion. London, Whurr 1999.
    16. Mannig WH. Clinical Decision Making in Fluency Disorders. Vancouver: Singular 2001.
    17. Ostatníková D. Anatómia, fyziológia a patofyziológia reči. Bratislava: Asklepios 2003.
    18. Sandrieser P, Schneider P. Stottern im Kindesalter. Stuttgart-New York: Thieme 2001.
    19. Seeman M. Poruchy dětské řeči. Praha: SZN 1955.
    20. Sovák M. Logopedie. Praha: SPN 1981.
    21. Van Riper Ch. The Nature of Stuttering. London: Prentice-Hall 1971.
    22. Wirth G. Sprachstörungen, Sprechstörungen, kindliche Hörstörungen. Köln: DAV 1990.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.